These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 36134065)

  • 21. Prevalence and quality of life and sleep in children and adolescents with restless legs syndrome/Willis-Ekbom disease.
    Sander HH; Eckeli AL; Costa Passos AD; Azevedo L; Fernandes do Prado LB; França Fernandes RM
    Sleep Med; 2017 Feb; 30():204-209. PubMed ID: 28215250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship among restless legs syndrome (Willis-Ekbom Disease), hypertension, cardiovascular disease, and cerebrovascular disease.
    Ferini-Strambi L; Walters AS; Sica D
    J Neurol; 2014 Jun; 261(6):1051-68. PubMed ID: 23963470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation.
    Garcia-Borreguero D; Silber MH; Winkelman JW; Högl B; Bainbridge J; Buchfuhrer M; Hadjigeorgiou G; Inoue Y; Manconi M; Oertel W; Ondo W; Winkelmann J; Allen RP
    Sleep Med; 2016 May; 21():1-11. PubMed ID: 27448465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restless legs syndrome/Willis Ekbom disease: new diagnostic criteria according to different nosology.
    Marelli S; Galbiati A; Rinaldi F; Giora E; Oldani A; Ferini Strambi L; Zucconi M
    Arch Ital Biol; 2015; 153(2-3):184-93. PubMed ID: 26742672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Olanzapine-induced restless leg syndrome (Willis-Ekbom disease): A case report.
    Das S; Prasad S; Anand A; Das A; Obinna Anugwom G; Oladunjoye F
    SAGE Open Med Case Rep; 2022; 10():2050313X221145583. PubMed ID: 36569038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gabapentin treatment in clozapine-induced restless legs syndrome: two cases and a review of the literature.
    Kumar V; Venkatasubramanian G
    Ther Adv Psychopharmacol; 2017 Jan; 7(1):42-47. PubMed ID: 28101323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "Emplotted Narratives" and Structured "Behavioral Observations" Supporting the Diagnosis of Willis-Ekbom Disease/Restless Legs Syndrome in Children with Neurodevelopmental Conditions.
    Ipsiroglu OS; Beyzaei N; Berger M; Wagner AL; Dhalla S; Garden J; Stockler S
    CNS Neurosci Ther; 2016 Nov; 22(11):894-905. PubMed ID: 27292821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restless arms syndrome: prevalence, impact, and management strategies.
    Ruppert E
    Neuropsychiatr Dis Treat; 2019; 15():1737-1750. PubMed ID: 31308668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential Diagnosis and Treatment of Restless Legs Syndrome: A Literature Review.
    Kwatra V; Khan MA; Quadri SA; Cook TS
    Cureus; 2018 Sep; 10(9):e3297. PubMed ID: 30443467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. THE RESTLESS LEGS SYNDROME (REVIEW).
    Japaridze G; Kasradze S; Maisuradze L; Popp R; Wetter T
    Georgian Med News; 2018 Dec; (285):74-81. PubMed ID: 30702074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Restless Legs Syndrome and Parkinson Disease: A Causal Relationship Between the Two Disorders?
    Ferini-Strambi L; Carli G; Casoni F; Galbiati A
    Front Neurol; 2018; 9():551. PubMed ID: 30087647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Key sleep neurologic disorders: Narcolepsy, restless legs syndrome/Willis-Ekbom disease, and REM sleep behavior disorder.
    St Louis EK
    Neurol Clin Pract; 2014 Feb; 4(1):16-25. PubMed ID: 24605270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton pump inhibitors and pain.
    Smith HS; Dhingra R; Ryckewaert L; Bonner D
    Pain Physician; 2009; 12(6):1013-23. PubMed ID: 19935988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review of quality of life instruments for the restless legs syndrome/Willis-Ekbom Disease (RLS/WED): critique and recommendations.
    Walters AS; Frauscher B; Allen R; Benes H; Chaudhuri KR; Garcia-Borreguero D; Lee HB; Picchietti DL; Trenkwalder C; Martinez-Martin P; Stebbins GT; Schrag A;
    J Clin Sleep Med; 2014 Dec; 10(12):1351-7. PubMed ID: 25348243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Restless Legs Syndrome/Willis-Ekbom Disease Morbidity: Burden, Quality of Life, Cardiovascular Aspects, and Sleep.
    Stevens MS
    Sleep Med Clin; 2015 Sep; 10(3):369-73, xv-xvi. PubMed ID: 26329447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered brain iron homeostasis and dopaminergic function in Restless Legs Syndrome (Willis-Ekbom Disease).
    Earley CJ; Connor J; Garcia-Borreguero D; Jenner P; Winkelman J; Zee PC; Allen R
    Sleep Med; 2014 Nov; 15(11):1288-301. PubMed ID: 25201131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic Treatment of Restless Legs Syndrome.
    Lv Q; Wang X; Asakawa T; Wang XP
    Curr Neuropharmacol; 2021; 19(3):372-382. PubMed ID: 33380302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Which Factors in Spinocerebellar Ataxia Type 3 Patients Are Associated with Restless Legs Syndrome/Willis-Ekbom Disease?
    Gitaí LLG; Éckeli AL; Sobreira-Neto MA; Diniz PRB; Santos AC; Júnior WM; Fernandes RMF
    Cerebellum; 2021 Feb; 20(1):21-30. PubMed ID: 32946033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restless Legs Syndrome/Willis-Ekbom Disease and Growing Pains in Children and Adolescents.
    Simakajornboon N; Dye TJ; Walters AS
    Sleep Med Clin; 2015 Sep; 10(3):311-22, xiv. PubMed ID: 26329441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Drug-induced restless legs syndrome].
    Ostroumova TM; Ostroumova OD; Filippova YA; Parfenov VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(4):129-135. PubMed ID: 32490630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.